Skip to content

The Effect of Allergic Rhinitis on Educational Outcomes

The Effect of Allergic Rhinitis on Educational Outcomes - a Register-based Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05881577
Enrollment
150000
Registered
2023-05-31
Start date
2023-02-15
Completion date
2023-07-31
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Brief summary

The study will assess the the burden of living with allergic rhinitis (AR) and the effect of AR on school performance for children and adolescents in Denmark.

Detailed description

The aim of the study is to investigate the effect of AR on school performance and examination test grades for children and adolescents diagnosed with AR early in life, as well as analyse their burden of disease and healthcare resource use using real-world data from the exhaustive Danish population registers. This is a retrospective registry analysis that uses Danish registers during 1994 and 2021. In Denmark, national registers collect data for the entire Danish population from birth to death and have done so for decades. This exhaustive data creates a sound foundation for this study of the impact of school performance caused by AR, as subjects can be traced with high certainty and detail over several years.

Interventions

OTHERObservational

Impact of AR on educational outcomes

Sponsors

Ernst & Young
CollaboratorUNKNOWN
ALK-Abelló A/S
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years

Inclusion criteria

* The main study population (cases) consists of children who have been diagnosed with AR before turning 13. Diagnosis of AR will be identified by dispensations of prescribed AR medications, ICD-10 codes of AR-related hospitalisations and reimbursement codes for AR-related healthcare contacts in the primary healthcare sector. At least two dispensed prescriptions of product containing intranasal corticosteroids (INCS) or antihistamines during the same calendar year for two consecutive years OR at least one visit with the primary healthcare sector with registered AR consultations AND at least one dispensed prescriptions of product containing INCS or antihistamines OR at least one contact with the hospital sector with an ICD-10 code for AR (primary or secondary diagnosis).

Exclusion criteria

* Children with their first AR-related healthcare contact or first AR-specific dispensed prescription at the age of 13 or older will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Primary school final examination test grades (oral and written) in: Language (Danish, English), Mathematics Obtained high school degree Obtained university degree1994-2021Test grades

Secondary

MeasureTime frameDescription
Cost of inpatient and outpatient hospitalisation1994-2021Cost in DKK
Cost of prescription medicine1994-2021Cost in DKK
Number of inpatient and outpatient visits1994-2021The number of inpatient/outpatients visits per year.

Countries

Denmark

Contacts

Primary ContactMercedes Romano, Pharm D, MBA
MRRDK@ALK.NET+4522971265
Backup ContactMikkel H Pedersen
Mikkel.H.Pedersen@dk.ey.com+4560177416

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026